We are very pleased to welcome CSL Behring, one of the largest biotech companies in the world, as a partner in BaseLaunch Phase II. Read the…
Jérémie Meyer30.07.2020
We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at…
Jérémie Meyer24.06.2020
We are proud to announce that BB Pureos Bioventures has become a partner in BaseLaunch Phase II as the first venture capital fund. Anja Harmeier,…
Jérémie Meyer08.06.2020
We are proud to announce that Roche has become a founding partner in the next phase of BaseLaunch. With this commitment, Roche renews its partnership…
Jérémie Meyer15.05.2020
Congratulations to one of BaseLaunch’s portfolio companies, Polyneuron on their latest milestone: First clinical trial application approval. Wishing you great success with the studies later…
Jérémie Meyer11.05.2020
There is an opportunity to participate in a research study interview taking place for those with knowledge of the biopharmaceutical industry in Switzerland. The research should…
Jérémie Meyer11.05.2020
We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing…
Jérémie Meyer11.05.2020
“Go start a biotech company in a strong biotech ecosystem” is our conclusion from this Nature paper, which tracks down every biotech start-up emerging (between…
Jérémie Meyer08.05.2020
Silvio Bonaccio is delighted by the strong entrepreneurial spirit that he encounters in his work as Head of ETH transfer. It took time, effort and…
Jérémie Meyer08.05.2020
